Skip to main content

Asuragen to Supply RNA Control Kits to Affymetrix for Molecular Dx

Premium

Asuragen said this week that it has signed an agreement to develop and manufacture RNA control kits for Affymetrix.

According to Asuragen, the kits are "intended for use with in vitro transcription reagent kits for clinical molecular diagnostic applications that Asuragen has licensed and supplied to Affymetrix."

The kits are configured for use with Affy's GeneChip System 3000Dx v.2.

Financial terms of the arrangement were not disclosed.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.